LONDON – Having become popular with both celebrities and investors, diabetes drugs that also promote weight loss, such as Novo Nordisk’s Ozempic, are now being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimer’s disease.
Diabetes regimens,…
Source: www.japantimes.co.jp – Read more
A key player in global clinical trials
Spain is emerging as a global powerhouse in clinical trials, accounting for a 4.1% share of global trials last year and being among the top